The Discounted Cash Flow (DCF) valuation of Cytosorbents Corp (CTSO) is (18.62) USD. With the latest stock price at 0.88 USD, the upside of Cytosorbents Corp based on DCF is -2214.0%.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| WACC / Discount Rate | 5.8% - 8.2% | 7.0% |
| Long-term Growth Rate | 3.0% - 5.0% | 4.0% |
| Fair Price | (69.93) - (11.12) | (18.62) |
| Upside | -8040.3% - -1362.1% | -2214.0% |